A comparative dosimetric study of volumetric-modulated arc therapy vs. fixed field intensity-modulated radiotherapy in postoperative irradiation of stage IB-IIA high-risk cervical cancer

Oncology Letters
Lili QiaoJiandong Zhang

Abstract

The aim of the present study was to compare the dosimetry features of volumetric-modulated arc therapy (VMAT) and fixed field intensity-modulated radiotherapy (f-IMRT) in postoperative irradiation of stage IB-IIA high-risk cervical cancer. Fifteen patients exhibiting stage IB-IIA high-risk cervical cancer, who had been treated with postoperative adjuvant concurrent radiochemotherapy, were selected. The clinical target volume (CTV) and organs at risk (OARs) were delineated according to contrast computed tomography images. The planning target volume (PTV) was subsequently produced by using 1 cm uniform expansion of the CTV. The treatment plans were intended to deliver 50 Gy in 25 fractions. The OARs that were contoured included the bladder, rectum, small bowel and femoral heads. Dose volume histograms were used to evaluate the dose distribution in the PTV and OARs. VMAT and f-IMRT treatment plans resulted in similar dose coverage of the PTV. VMAT was superior to f-IMRT in conformity (P<0.05), and resulted in a reduction of OARs irradiated at high dose levels (V40 and V50) compared with f-IMRT (P<0.05), particularly for the bladder. However, the doses of low levels (V10 and V20) delivered to OARs with f-IMRT were slightly reduced ...Continue Reading

References

Jul 1, 1991·International Journal of Radiation Oncology, Biology, Physics·P W Grigsby, C A Perez
Sep 6, 2003·International Journal of Radiation Oncology, Biology, Physics·Jian Z WangRobert D Stewart
Oct 4, 2005·International Journal of Radiation Oncology, Biology, Physics·Alexandra TaylorMelanie E B Powell
Apr 19, 2006·International Journal of Radiation Oncology, Biology, Physics·Eric J Hall
Jul 4, 2006·Seminars in Radiation Oncology·Marcus E Randall, Geoffrey S Ibbott
Jul 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bradley J MonkWui-Jin Koh
Aug 12, 2008·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Luca CozziAntonella Fogliata
Apr 14, 2009·International Journal of Radiation Oncology, Biology, Physics·Wilko F A R VerbakelSuresh Senan
Sep 15, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Matthias GuckenbergerMichael Flentje
Sep 22, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dirk WolffFrank Lohr
Jan 2, 2010·International Journal of Radiation Oncology, Biology, Physics·Sua YooFang-Fang Yin
Mar 9, 2010·International Journal of Radiation Oncology, Biology, Physics·Charles S MayoRichard Moser
Mar 27, 2010·International Journal of Radiation Oncology, Biology, Physics·Piet DirixSandra Nuyts
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Aug 3, 2010·Clinical Oncology : a Journal of the Royal College of Radiologists·J Staffurth, UNKNOWN Radiotherapy Development Board
Mar 9, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jin Hwi KimSoo Young Hur
Aug 3, 2012·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Guangyu ZhangYufeng Cheng
Apr 13, 2013·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·Kham NguyenJohn Garcia

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
hysterectomy
dissection

Software Mentioned

SPSS
[UNK] Treatment Planning System
Progressive Resolution Optimizer ( PRO

Related Concepts

Related Feeds

Buruli Ulcer

Buruli ulcer is a progressive disease of subcutaneous tissues caused by mycobacterium ulcerans. Here is the latest research.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

© 2022 Meta ULC. All rights reserved